nicotinamide N-methyltransferase antisense oligonucleotides (Ionis/Beth Israel Deaconess Medical Center)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenicotinamide N-methyltransferase antisense oligonucleotides (Ionis/Beth Israel Deaconess Medical Center)
Drug Alias Namenicotinamide N-methyltransferase antisense oligonucleotides (Isis Pharmaceuticals/Beth Israel Deaconess Medical Center)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionNicotinamide N-methyltransferase inhibitors
TargetsNicotinamide N-methyltransferase
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeth Israel Deaconess Medical CenterIonis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A